← All trials
NCT05717153
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 28, 2023
- Primary completion
- Jan 15, 2027
- Completion date
- Sep 15, 2027
- First posted
- Feb 8, 2023
- Last posted
- Dec 26, 2023
- Enrollment
- 15
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mayo ClinicLead sponsor
- National Cancer Institute (NCI)Collaborator
- Mayo ClinicOverall official - principal investigator
- Mayo ClinicReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.